BriaCell Therapeutics Corp.
BCTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001610820
No open-market purchases or sales by BriaCell Therapeutics Corp. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $1.58M in total; no superinvestor holds it.
Holders of 5% or more of BCTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of BriaCell Therapeutics Corp., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Plambeck Jeremy Myung Jae | 13G | 100.00%13.3K shares | New | Oct 10, 20251 filing | Oct 10, 2025 | SEC |
| Iroquois Capital Management, LLC | 13G | 9.10%1.60M shares | New | Jul 28, 20251 filing | Jul 28, 2025 | SEC |
| Copia Fund (Cayman) LP | 13G | 5.10%818.4K shares | New | Jan 8, 20241 filing | Jan 8, 2024 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on BriaCell Therapeutics Corp., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 7, 20254:47 PM ET | CVI Investments, Inc.and 1 other | 13G/A | 4.90%98.9K shares | −0.80 ppfrom 5.70%Below 5% | Sep 30, 2025 | SEC |
| Oct 10, 202512:31 PM ET | Plambeck Jeremy Myung Jae | 13G | 100.00%13.3K shares | New | Aug 25, 2025 | SEC |
| Jul 28, 202511:38 AM ET | Iroquois Capital Management, LLCand 2 others | 13G | 9.10%1.60M shares | New | Jul 15, 2025 | SEC |
| Jul 22, 20259:59 AM ET | CVI Investments, Inc.and 1 other | 13G | 5.70%1.00M shares | +0.80 ppfrom 4.90% | Jul 15, 2025 | SEC |
| Jul 21, 202511:16 AM ET | CVI Investments, Inc.and 1 other | 13G/A | 4.90%355.9K shares | −3.70 ppfrom 8.60%Below 5% | Jun 30, 2025 | SEC |
| May 13, 20259:08 PM ET | 3i, LPand 2 others | 13G/A | 4.90%190.0K shares | −5.00 ppfrom 9.90%Below 5% | Mar 31, 2025 | SEC |
| May 1, 202510:01 AM ET | CVI Investments, Inc.and 1 other | 13G | 8.60%489.2K shares | New | Apr 24, 2025 | SEC |
| Feb 10, 20259:02 PM ET | 3i, LPand 2 others | 13G | 9.90%369.0K shares | New | Feb 5, 2025 | SEC |
| Jan 8, 202411:01 AM ET | Copia Fund (Cayman) LP | 13G | 5.10%818.4K shares | New | Dec 29, 2023 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell BriaCell Therapeutics Corp. shares.
No Form 144 notices for BriaCell Therapeutics Corp. are on file.